The Hypoglycemic Effect of Saururus chinensis Baill in Animal Models of Diabetes Mellitus |
Joo, Hee-Jeong
(Biohealth Product Research Center, School of Food and Life Science, Institute for Food Sciences, Inje University)
Kang, Ming-Jung (Biohealth Product Research Center, School of Food and Life Science, Institute for Food Sciences, Inje University) Seo, Tae-Jin (Biohealth Product Research Center, School of Food and Life Science, Institute for Food Sciences, Inje University) Kim, Hyun-A (Biohealth Product Research Center, School of Food and Life Science, Institute for Food Sciences, Inje University) Yoo, Sung-Ja (Biohealth Product Research Center, School of Food and Life Science, Institute for Food Sciences, Inje University) Lee, Soo-Kyung (Biohealth Product Research Center, School of Food and Life Science, Institute for Food Sciences, Inje University) Lim, Hwa-Jae (Department of Food and Nutrition, Dong-eui University) Byun, Boo-Hyeong (Department of Oriental Medicine, Daegu Haany University) Kim, Jung-In (Biohealth Product Research Center, School of Food and Life Science, Institute for Food Sciences, Inje University) |
1 | The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl. J. Med. 329: 977-986 (1993) DOI ScienceOn |
2 | UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352: 837-853 (1998) DOI ScienceOn |
3 | Fujita H, Yamagami T, Ohshima K. Fermented soybean-derived touchi extract with anti-glycaemic effect via -glucosidase inhibitory action in rats and humans. J. Nutr. 131: 1211-1213 (2001) |
4 | Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka TA, Matsuhisa M, Yamasaki Y. Role af oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic -cell dysfunction and insulin resistance. Int. J. Biochem. Cell Biol. 37: 1595-1608 (2005) DOI ScienceOn |
5 | Inoue I, Takahashi K, Noji S, Awata T, Negishi K, Katayama S. Acarbose controls postprandial hyper-proinsulinemia in non-insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pr. 36: 143-151 (1997) DOI ScienceOn |
6 | Baron AD. Postprandial hyperglycaemia and -glucosidase inhibitors. Diabetes Res. Clin. Pr. 40: S51-55 (1998) DOI ScienceOn |
7 | Fujita H, Yamagami J. Fermented soybean-derived touchi-extract with anti-diabetic eftect via alpha-glucosidase inhibitory action in a long-term administration study with KKAy mice. Life Sci. 70: 219-227 (2001) DOI ScienceOn |
8 | Holman RR, Cull CA, Turner RC. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44) Diabetes Care 22: 960-964 (1999) DOI ScienceOn |
9 | Seifarth C, Bergmann Y, Bergmann J, Holst JJ, Schmiegel W, Nauck M. Prolonged and enhanced secretion of glucagon like peptide-1 (7-36 amide) after oral sucrose due to alpha glucosidase inhibition (acarbose) in type 2 diabetic patients. Diabetic Med. 15: 485-91 (1998) DOI ScienceOn |
10 | Lebovitz HE. -Glucosidase inhibitors as agents in the treatment of diabetes. Diabetes Rev. 6:132-145 (1998) |
11 | Mertes G. Efficacy and safety of acarbose in the treatment of type 2 diabetes: data from a 2-year surveillance study. Diabetes Res. Clin. Pr. 40: 63-70 (1998) DOI ScienceOn |
12 | Mertes G. Safety and efficacy of acarbose in the treatment of type 2 diabetes: data from a 5-year surveillance study Diabetes Res. Clin. Pr. 52: 193-204 (2001) DOI ScienceOn |
13 | Campbell RK, White JR, Nomura D. The clinical importance of postprandial hyperglycemia. Diabetes Educator 27: 624-637 (2001) DOI |
14 | King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025 Prevalence, numerical estimates and projections. Diabetes Care 21: 1414-1431 (1998) DOI ScienceOn |
15 | Mooradian AD, Thurman JE. Drug therapy of postprandial hyperglycemia. Drugs 57: 19-29 (1999) DOI ScienceOn |
16 | Kwon CS, Son KH, Kim JS. Effect of Lonicera japonica flower on body weight gain and glucose tolerance in rodents. Food Sci. Biotechnol. 13: 768-771 (2004) |
17 | Hanefeld M. The role of acarbose in the treatment of non-insulin-dependent diabetes mellitus. J. Diabetes Complicat. 12: 228-237 (1998) DOI ScienceOn |
18 | Coutinho M, Gerstein H, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. Diabetes Care 22: 233-240 (1999) DOI ScienceOn |
19 | Saito N, Sakai H, Sekihara H, Yajima Y. Effect of an -glucosidase inhibitor (voglibose), in combination with sulphonylureas, on glycaemic control in type 2 diabetes subjects. J. Int. Med. Res. 26: 219-232 (1998) DOI |
20 | Balflour JA, McTavish D. Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitus. Drugs 46: 1025-54 (1993) DOI ScienceOn |
21 | Soonthornpun S, Rattarasarn C, Leelawattana R, Setasuban W. Postprandial plasma glucose: a good index of glycemic control in type 2 diabetic patients having near-normal fasting glucose levels. Diabetes Res. Clin. Pr. 46: 23-27 (1999) DOI ScienceOn |
22 | Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). Brit. Med. J. 322: 1-6 (2001) DOI |
23 | Matsui T, Yoshimoto C, Osajima K, Oki T, Osajima Y, Oki T, Osajima Y. In vitro survey of -glucosidase inhibitory food components. Biosci. Biotechnol. Biochem. 60: 2019-2022 (1996) DOI ScienceOn |
24 | Stand E, Baumgartl HJ, Fuchtenbusch M, Stemplinger J. Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy. Diabetes Obes. Metab. 1: 215-220 (1999) DOI ScienceOn |
25 | Hanefeld M. The Role of acarbose in the treatment of non-insulin-dependent diabetes mellitus. J. Diabetes Complicat. 12: 228-237 (1998) DOI ScienceOn |
26 | Coniff RF, Shapiro JA, Robbins D, Kleinfield R, Seaton TB, Beisswenger P, McGill JB. Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. Diabetes Care 18: 817-824 (1995) DOI ScienceOn |
27 | Choi CW, Kim SC, Hwang SS, Choi BK, Ahn HJ, Lee MY, Park SH, Kim SK. Antioxidant activity and free radical scavenging capacity between Korean medicinal plants and flavonoids by assay-guided comparison. Plant Sci. 163: 1161-1168 (2002) DOI ScienceOn |
28 | Watanabe J, Kawabata J, Kurihara H, Niki R. Isolation and identification of -glucosidase inhibitors from Tochu-cha (Encommia ulmoides). Biosci. Biotechnol. Biochem. 61: 177-178 (1997) DOI ScienceOn |
29 | Qualmann C, Nauck MA, Holst JJ, Orskov C, Creutzfeldt W. Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose). Scand. J. Gastroenterol. 30: 892-896 (1995) DOI |
30 | Chung BS, Shin MG. Dictionary of Korean Folk Medicine. Young Lim Sa, Seoul, Korea. p. 813 (1990) |
31 | Meneilly GS, Ryan EA, Radziuk J. Effect of acarbose on insulin sensitivity in elderly patients with diabetes. Diabetes Care 23: 1162-1167 (2000) DOI ScienceOn |
32 | Seifarth C, Bergmann J, Holst JJ, Ritzel R, Schmiegel W, Nauck MA. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in type 2 diabetic patients. Diabetic Med. 15: 485-491 (1998) DOI ScienceOn |
33 | Youn JY, Park HY, Cho KH. Anti-hyperglycemic activity of Commelina communis L.: inhibition of -glucosidase. Diabetes Res. Clin. Pr. 66S: S149-155 (2004) |
34 | Lee WS, Baek Y-I, Kim J-R, Cho K-H, Sok D-E, Jeong T-S. Antioxidant activities of a new lignan and a neolignan from Saururus chinensis. Bioorg. Med. Chem. Lett. 14: 5623-5628 (2004) DOI ScienceOn |
35 | Bressler R, Johnson D. New pharmacological approaches to therapy of NIDDM. Diabetes Care 15: 792-805 (1992) DOI ScienceOn |
36 | Shim YJ, Doo HK, Ahn SY, Kim YS, Seong JK, Park IS, Min BH. Inhibitory effect of aqueous extract from the gall of Rhus chinensis on alpha-glucosidase activity and postprandial blood glucose. J. Ethnopharmacol. 85: 283-287 (2003) DOI ScienceOn |
37 | Nishioka T, Kawabata J, Aoyama Y. Baicalein, an alpha-glucosidase inhibitor from Scutellaria baicalensis. J. Nat. Prod. 61: 1413-1415 (1998) DOI ScienceOn |
38 | Sels JP, Huijberts MS, Wolffenbuttel BH. Miglitol, a new alpha-glucosidase inhibitor. Expert Opin. Pharmaco. 1: 149-156 (1999) DOI ScienceOn |